Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Caverject 20 micrograms powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection. A white to off-white powder. |
Alprostadil 20 micrograms.
When reconstituted, each 1ml delivers a dose of 20 micrograms of alprostadil.
Excipients with known effect:
Each 1ml of reconstituted solution contains 8.04 mg of benzyl alcohol.
Sodium
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Alprostadil |
Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Single pack containing a 5 ml clear, colourless, glass vial of Caverject 20 micrograms powder with a bromobutyl rubber stopper and an aluminium overseal with polypropylene flip-off cap.
Packs also each contain a syringe of solvent, a sterile 22G and a 30G needle plus a preinjection swab.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0942
4 August 2010
| Drug | Countries | |
|---|---|---|
| CAVERJECT | Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Malta, Mexico, New Zealand, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
